Analytical Data
-
Gene name
S100A15
- Application
-
Alternative Names
S100A7A; S100A7L1; S100A7f; S100 calcium-binding protein A7-like 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q86SG5
-
Expression Region
Ser2~Gln101
-
Molecular Weight
15kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100A15 is a member of the S100 protein family, known for its role in various intracellular and extracellular processes, including cell growth, differentiation, and motility. The primary interest in researching S100A15 is its involvement in inflammatory responses and its potential implications in various skin diseases, particularly psoriasis and other inflammatory skin disorders. Elevated levels of S100A15 have been observed in psoriatic lesions, suggesting its role as a biomarker for disease activity and a potential therapeutic target. Moreover, S100A15 has been implicated in the modulation of the immune response, influencing the behavior of immune cells, such as keratinocytes and T cells. Understanding the molecular mechanisms underlying the function of S100A15 and its interactions within the immune system could provide insights into novel therapeutic approaches for treating inflammatory conditions. The generation of recombinant S100A15 protein allows for in-depth studies on its structural characteristics, functional roles, and potential interactions with other proteins. This research aims to elucidate the precise biological functions of S100A15 in inflammation and its therapeutic potential, ultimately contributing to more effective treatments for related skin diseases.
